Oppenheimer Boosts The Cigna Group (NYSE:CI) Price Target to

The Cigna Group (NYSE:CI – Free Report) had its price target boosted by Oppenheimer from $370.00 to $400.00 in a research note released on Friday, Benzinga reports. Oppenheimer currently has an outperform rating on the health services provider’s stock. A number of other research firms also recently commented on CI. Cantor Fitzgerald reiterated an overweight […]

Related Keywords

United States , Ericp Palmer , Hoeltzel Maryt Agoglia , , Wells Fargo Company , Barclays , Capital Asset Advisory Services , Cigna Group , Somerset Trust Co , Its Evernorth Health Services , Securities Exchange Commission , Cantor Fitzgerald , Deutsche Bank Aktiengesellschaft , Cigna Group Price Performance , First Financial Corp , Cigna Group Daily , Cigna Group Dividend Announcement , Capital Advisors Ltd , Free Report , Bank Aktiengesellschaft , Wells Fargo , Get Free Report , Exchange Commission , Doremus Investment Management , Asset Advisory Services , Financial Corp , The Cigna Group , Nyse Ci , Ci , Medical , 12550910 , Boost Price Target , Oppenheimer Holdings Inc ,